Accessibility settings

Published on in Vol 14 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72242, first published .
Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study

Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study

Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study

Kazuki Aoyama   1 * , MD ;   Yuya Nakajima   2 * , MD, PhD ;   Shu Meguro   1 , MD, PhD ;   Yasunori Sato   3 * , PhD ;   Rei Goto   4 * , MD, PhD ;   Mariko Hida   5 * , MD, PhD ;   Takeshi Arimitsu   5 , MD, PhD ;   Yoshifumi Kasuga   6 , MD, PhD ;   Mamoru Tanaka   6 , MD, PhD ;   Hiroshi Itoh   2 * , MD, PhD ;   Kaori Hayashi   1 , MD, PhD

1 Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan

2 Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan

3 Department of Biostatistics, Keio University School of Medicine, Tokyo, Japan

4 Graduate School of Business Administration, Keio University,, Kanagawa, Japan

5 Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan

6 Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan

*these authors contributed equally

Corresponding Author:

  • Kazuki Aoyama, MD
  • Department of Endocrinology, Metabolism and Nephrology
  • Keio University School of Medicine
  • 35 Shinanomachi, Shinjuku-ku
  • Tokyo 160-0016
  • Japan
  • Phone: 81 3-5363-3797
  • Email: aoyama.3105@gmail.com